Olaf Ritzeler

Olaf Ritzeler is a seasoned professional in the pharmaceutical industry, currently working at Sanofi in a key business development and licensing role. Here's an overview of his profile:

Current Position

Olaf Ritzeler recently started a new position as BD&L, Director, Search & Evaluation for Immunology & Inflammation at Sanofi.2 This role focuses on identifying and evaluating new opportunities in the immunology and inflammation therapeutic areas.

Background and Expertise

Drug Discovery and Development:: Dr. Ritzeler has extensive experience in drug discovery and development, with over 20 years in the pharmaceutical industry.

External Innovation:: In his previous role at Sanofi, he served as a director of external innovation for Rare and Neurological diseases.4 This position involved scouting for external opportunities and partnerships.

Business Development:: Olaf has a strong background in business development and licensing, particularly in identifying and evaluating potential collaborations and innovations in the pharmaceutical sector.

Education

Dr. Ritzeler received his education from the University of Bern.4

Professional Activities

1. Conference Participation: Olaf regularly attends industry events. He recently registered for BIO-Europe Spring 2024, a major partnering event in the biotech industry.3

2. Speaking Engagements: He has been invited as a speaker at conferences such as the Drug Discovery Nexus 2018, where he shared insights on external opportunities in the pharmaceutical industry.5

3. Innovation Focus: Olaf is involved in Sanofi's efforts to partner with academic institutions and identify novel research in areas such as rare diseases.1

Inventions

Olaf Ritzeler has been involved in pharmaceutical innovation, having filed for multiple patents related to his work in drug discovery and development.6

Olaf Ritzeler's career demonstrates a strong commitment to advancing pharmaceutical research and development through strategic partnerships, external innovation, and a focus on addressing unmet medical needs in areas such as rare diseases, immunology, and inflammation.